Loading insider details...
Beta
Latest Form 4 (Oct 13, 2026): Exercise/Conversion of 3,910 RLYB shares, $23.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 13, 2026 | Rallybio Corp (RLYB) | Exercise/Conversion | 3,910 | $23.8K |
| Oct 1, 2026 | Rallybio Corp (RLYB) | Exercise/Conversion | 5,000 | $30.4K |
| Sep 2, 2026 | Decoy Therapeutics Inc. (DCOY) | Grant/Award | 2,000 | n/a |
| Feb 23, 2026 | Rallybio Corp (RLYB) | Grant/Award | 2,500 | n/a |
| Feb 20, 2025 | Rallybio Corp (RLYB) | Grant/Award | 180,000 | n/a |
| Feb 22, 2024 | Salarius Pharmaceuticals, Inc. (SLRX) | Grant/Award | 20,500 | n/a |
| Feb 16, 2024 | Rallybio Corp (RLYB) | Grant/Award | 120,000 | n/a |
| Mar 16, 2023 | Rallybio Corp (RLYB) | Purchase | 5,000 | $26.1K |
| Feb 1, 2023 | Rallybio Corp (RLYB) | Grant/Award | 240,000 | n/a |
| Jan 5, 2023 | Salarius Pharmaceuticals, Inc. (SLRX) | Grant/Award | 1,440 | n/a |